ESR1 and breast adenocarcinoma: To determine the mechanism underlying GR-mediated repression of ERα activity and the subsequent effect on E2-ERα-mediated cell proliferation, we used an ERα- and GR-positive human breast adenocarcinoma cell line MCF-7 as a model system.